eHealth (EHTH) Stock Price, News & Analysis

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for eHealth in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" EHTH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EHTH, but not buy additional shares or sell existing shares.
View EHTH analyst ratings or view top-rated stocks.

4 equities research analysts have issued 12-month price objectives for eHealth's stock. Their EHTH share price targets range from $7.00 to $13.00. On average, they expect the company's stock price to reach $10.00 in the next twelve months. This suggests a possible upside of 125.2% from the stock's current price.
View analysts price targets for EHTH or view top-rated stocks among Wall Street analysts.

eHealth's stock was trading at $8.72 at the beginning of 2024. Since then, EHTH stock has decreased by 49.1% and is now trading at $4.44.
View the best growth stocks for 2024 here.

eHealth saw a decline in short interest in March. As of March 31st, there was short interest totaling 1,110,000 shares, a decline of 9.0% from the March 15th total of 1,220,000 shares. Based on an average trading volume of 308,200 shares, the short-interest ratio is currently 3.6 days.
View eHealth's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our EHTH earnings forecast.

eHealth will be holding an earnings conference call on Tuesday, May 7th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

eHealth, Inc. (NASDAQ:EHTH) released its earnings results on Tuesday, February, 27th. The financial services provider reported $1.27 earnings per share for the quarter, missing the consensus estimate of $1.83 by $0.56. The financial services provider earned $247.70 million during the quarter, compared to analysts' expectations of $244.93 million. eHealth had a negative net margin of 6.23% and a negative trailing twelve-month return on equity of 5.54%. The business's revenue for the quarter was up 26.2% compared to the same quarter last year. During the same period in the previous year, the business posted $1.01 earnings per share.

Global X E-Commerce ETF holds 25,267 shares of EHTH stock, representing 0.16% of its portfolio.

eHealth issued an update on its FY 2024 earnings guidance on Thursday, April, 18th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $450.0 million-$475.0 million, compared to the consensus revenue estimate of $461.7 million.

60 employees have rated eHealth Chief Executive Officer Scott Flanders on Glassdoor.com. Scott Flanders has an approval rating of 67% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other eHealth investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Advanced Micro Devices (AMD), AbbVie (ABBV), Tesla (TSLA), Netflix (NFLX), Salesforce (CRM), DocuSign (DOCU) and JPMorgan Chase & Co. (JPM).

eHealth's stock is owned by a variety of institutional and retail investors. Top institutional investors include Los Angeles Capital Management LLC (0.31%). Insiders that own company stock include A John Hass, Dale B Wolf, Francis S Soistman Jr, Gavin G Galimi, Phillip A Morelock and Timothy C Hannan.
View institutional ownership trends.

Shares of EHTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.